The economic impact of overactive bladder syndrome in six Western countries

To calculate up‐to‐date estimates of the economic impact of overactive bladder syndrome (OAB) with and without urgency urinary incontinence (UUI) on the health sector of six countries (Canada, Germany, Italy, Spain, Sweden and the UK), as OAB is a significant health concern for adults aged >18 years living in Western countries.

[1]  L. Curtis,et al.  Unit Costs of Health and Social Care 2016 , 2015 .

[2]  K. Coyne,et al.  The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well‐being in men and women: results from the EPIC study , 2008, BJU international.

[3]  P. Abrams,et al.  Symptom bother and health care-seeking behavior among individuals with overactive bladder. , 2008, European urology.

[4]  T. H. Klotz,et al.  The economic costs of overactive bladder in Germany. , 2007, European urology.

[5]  A. Wagg,et al.  Lower urinary tract symptoms, incontinence and falls in elderly people: time for an intervention study , 2007, International journal of clinical practice.

[6]  K. Coyne,et al.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. , 2006, European urology.

[7]  C. Kelleher,et al.  The current and future burden and cost of overactive bladder in five European countries. , 2006, European urology.

[8]  G. Bagetta,et al.  Outcomes of a pharmacoepidemiological survey on the antibiotic treatment of uncomplicated acute cystitis in community. , 2006, Pharmacological research.

[9]  D. Revicki,et al.  The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  C. Lucioni,et al.  Analisi di costo-efficacia della terapia combinata con pioglitazone nel trattamento del diabete mellito di tipo 2 in Italia , 2004 .

[11]  F. Debruyne,et al.  Clinical and socioeconomic relevance of overactive bladder. , 2004, Urology.

[12]  Teh-Wei Hu,et al.  Costs of urinary incontinence and overactive bladder in the United States: a comparative study. , 2004, Urology.

[13]  M. Maranghi,et al.  Impact of fractures on health care in a major university hospital in Rome , 2003, Aging clinical and experimental research.

[14]  T. Wagner,et al.  Estimated economic costs of overactive bladder in the United States. , 2003, Urology.

[15]  W. Stewart,et al.  Prevalence and burden of overactive bladder in the United States , 2003, World Journal of Urology.

[16]  T. Wagner,et al.  Health-related consequences of overactive bladder. , 2002, The American journal of managed care.

[17]  Magnus Fall,et al.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. , 2003, Urology.

[18]  I. Milsom,et al.  Incontinence aids in Sweden: users and costs , 2001, BJU international.

[19]  L. Subak,et al.  Annual Direct Cost of Urinary Incontinence , 2001, Obstetrics and gynecology.

[20]  P. Abrams,et al.  How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study , 2001, BJU international.

[21]  B. Jönsson,et al.  Costs, quality of life and disease severity in multiple sclerosis: a cross‐sectional study in Sweden , 2001, European journal of neurology.

[22]  C. Kelleher,et al.  Overactive bladder significantly affects quality of life. , 2000, The American journal of managed care.

[23]  T. Wagner,et al.  Economic considerations in overactive bladder. , 2000, The American journal of managed care.

[24]  E. Vittinghoff,et al.  Urinary Incontinence: Does it Increase Risk for Falls and Fractures? , 2000, Journal of the American Geriatrics Society.

[25]  上谷 さゆり.  QOL (Quality of Life) , 2000, International Archives of Allergy and Immunology.

[26]  L. Pientka,et al.  Die Kosten hüftgelenksnaher Frakturen in Deutschland: Eine prospektive Untersuchung , 1999, Zeitschrift für Gerontologie und Geriatrie.

[27]  W. Steers,et al.  Urinary incontinence and depression. , 1999, The Journal of urology.

[28]  T. Wagner,et al.  Economic costs of urinary incontinence in 1995. , 1998, Urology.

[29]  S. K. Van Den Eeden,et al.  Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. , 1997, Age and ageing.

[30]  I. Milsom,et al.  Urinary incontinence. Social and financial costs high. , 1993, BMJ.

[31]  T. Hu,et al.  Impact of Urinary Incontinence on Health‐Care Costs , 1990, Journal of the American Geriatrics Society.

[32]  R L Kane,et al.  The Costs of Urinary Incontinence in Nursing Homes , 1984, Medical care.

[33]  P. Oakes,et al.  Unit Costs of Health and Social Care 2006 , 2006 .

[34]  M. De Hert,et al.  Cost of disorders of the brain in Europe. , 2006, European journal of neurology.

[35]  O. Johnell,et al.  Costs and quality of life associated with osteoporosis-related fractures in Sweden , 2005, Osteoporosis International.

[36]  M. Beckmann,et al.  Psychosomatic aspects of urinary incontinence , 1999, Archives of Gynecology and Obstetrics.

[37]  J. Cabasés,et al.  Incidencia, riesgo y evolución de las fracturas osteoporóticas de cuello de fémur en las mujeres en España, a partir de un modelo de Markov , 1998 .

[38]  G. Becker,et al.  Human Capital: A Theoretical and Empirical Analysis with Special Reference to Education, Third Edition , 1993 .